Jing L. Marantz - Oct 7, 2024 Form 4 Insider Report for Scholar Rock Holding Corp (SRRK)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Junlin Ho, Attorney-in-Fact for Jing L. Marantz
Stock symbol
SRRK
Transactions as of
Oct 7, 2024
Transactions value $
-$2,036,936
Form type
4
Date filed
10/7/2024, 08:51 PM
Previous filing
Jun 18, 2024
Next filing
Nov 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRRK Common Stock Options Exercise $940K +109K +150.13% $8.59 182K Oct 7, 2024 Direct F1
transaction SRRK Common Stock Sale -$1.73M -67.4K -37.01% $25.59* 115K Oct 7, 2024 Direct F1, F2
transaction SRRK Common Stock Sale -$66.9K -2.55K -2.22% $26.22* 112K Oct 7, 2024 Direct F1, F3
transaction SRRK Common Stock Sale -$1.18M -39.4K -35.08% $30.06* 72.9K Oct 7, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRRK Stock Option (Right to Buy) Options Exercise $0 -109K -43.75% $0.00 141K Oct 7, 2024 Common Stock 109K $8.59 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.335, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F5 Options vest over four years with 25% vesting on November 9, 2023 and the remainder vesting in 12 quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.